Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

For patients who are significantly overweight -- the path forward to losing it may include a decision between drugs or ...

Taking a GLP-1 receptor agonist prior to bariatric surgery may not boost long-term weight loss and metabolic benefits, a ...

According to market research, the industry is expected to expand from a valuation of USD 1,850.3 million in 2024 to an estimated USD 3,440.8 million by 2034. This robust growth trajectory is being ...

Abby Luce was tired of always being behind the camera. For years, she’d be the one taking the photos of her groups of friends ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...

Healthcare professionals and people with obesity endorse recommendations for the safe practice of bariatric and metabolic ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.